Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength.

Biotech stocks set for a rebound in 2024, analysts say Investors warm up to sector amid stabilizing rates and an uptick in dealmaking Last Updated: Dec. 23, 2023 at 6:50 a.m. ET First Published ...

Meanwhile, if you buy the shares while they're down, you will have gotten in on the stock for a bargain -- and can maximize ...

In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...

However, that all seems to be history this year as biotech stocks have begun to rebound due to a wave of FDA approvals, which started in 2023. In fact, over the last two years, ...

While the stock’s fallen over the last five years, it’s seen a rebound in 2023, posting a 33% gain. ... This is definitely one of the biotech stocks to watch.

Biotechnology is certainly on the list, if not at the top, of high-growth industries in dire need of a rebound. Following enthusiasm for COVID-19 vaccines in late 2020 and part of 2021 ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

July 28, 2022 - Investors are still feeling the burn from biotech's flameout. And with rising interest rates and increasingly strict regulatory scrutiny, it's no wonder they remain wary of being ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

Biotech stocks have been hit by 'DOGE' and other fears. Why they're a great value now. Provided by Dow Jones Mar 27, 2025, 5:11:00 PM. By Michael Brush .